Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease.

Standard

Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. / Betz, Regina C; Pforr, Jana; Flaquer, Antonia; Redler, Silke; Hanneken, Sandra; Eigelshoven, Sibylle; Kortüm, Anne-Katrin; Tüting, Thomas; Lambert, Julien; Jozef, De Weert; Hillmer, Axel M; Schmael, Christine; Wienker, Thomas F; Kruse, Roland; Lutz, Gerhard; Blaumeiser, Bettina; Nöthen, Markus M.

in: J INVEST DERMATOL, Jahrgang 127, Nr. 11, 11, 2007, S. 2539-2543.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Betz, RC, Pforr, J, Flaquer, A, Redler, S, Hanneken, S, Eigelshoven, S, Kortüm, A-K, Tüting, T, Lambert, J, Jozef, DW, Hillmer, AM, Schmael, C, Wienker, TF, Kruse, R, Lutz, G, Blaumeiser, B & Nöthen, MM 2007, 'Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease.', J INVEST DERMATOL, Jg. 127, Nr. 11, 11, S. 2539-2543. <http://www.ncbi.nlm.nih.gov/pubmed/17581619?dopt=Citation>

APA

Betz, R. C., Pforr, J., Flaquer, A., Redler, S., Hanneken, S., Eigelshoven, S., Kortüm, A-K., Tüting, T., Lambert, J., Jozef, D. W., Hillmer, A. M., Schmael, C., Wienker, T. F., Kruse, R., Lutz, G., Blaumeiser, B., & Nöthen, M. M. (2007). Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J INVEST DERMATOL, 127(11), 2539-2543. [11]. http://www.ncbi.nlm.nih.gov/pubmed/17581619?dopt=Citation

Vancouver

Bibtex

@article{38d5b45e5bc84f239470e410d65a315b,
title = "Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease.",
abstract = "Alopecia areata (AA) is a common dermatological disease, which affects nearly 2% of the general population. Association of AA with atopic disease has been repeatedly reported. Loss-of-function mutations in the filaggrin gene (FLG) may be considered as promising candidates in AA, as they have been observed to be a strong risk factor in atopic dermatitis. The FLG mutations R501X and 2282del4 were genotyped in a large sample of AA patients (n=449) and controls (n=473). Although no significant association was observed in the patient sample overall, FLG mutations were significantly associated with the presence of atopic dermatitis among AA patients. Furthermore, the presence of FLG mutations had a strong impact on the clinical course of AA in comorbid patients. For example, 19 of the 22 mutation carriers among AA patients with atopic dermatitis showed a severe form of the disease (P=0.003; odds ratio (OR)=5.47 (95% confidence interval (CI): 1.59-18.76)). In conclusion, our data suggest that when AA occurs in conjunction with FLG-associated atopic disorder, the clinical presentation of AA may be more severe.",
author = "Betz, {Regina C} and Jana Pforr and Antonia Flaquer and Silke Redler and Sandra Hanneken and Sibylle Eigelshoven and Anne-Katrin Kort{\"u}m and Thomas T{\"u}ting and Julien Lambert and Jozef, {De Weert} and Hillmer, {Axel M} and Christine Schmael and Wienker, {Thomas F} and Roland Kruse and Gerhard Lutz and Bettina Blaumeiser and N{\"o}then, {Markus M}",
year = "2007",
language = "Deutsch",
volume = "127",
pages = "2539--2543",
journal = "J INVEST DERMATOL",
issn = "0022-202X",
publisher = "NATURE PUBLISHING GROUP",
number = "11",

}

RIS

TY - JOUR

T1 - Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease.

AU - Betz, Regina C

AU - Pforr, Jana

AU - Flaquer, Antonia

AU - Redler, Silke

AU - Hanneken, Sandra

AU - Eigelshoven, Sibylle

AU - Kortüm, Anne-Katrin

AU - Tüting, Thomas

AU - Lambert, Julien

AU - Jozef, De Weert

AU - Hillmer, Axel M

AU - Schmael, Christine

AU - Wienker, Thomas F

AU - Kruse, Roland

AU - Lutz, Gerhard

AU - Blaumeiser, Bettina

AU - Nöthen, Markus M

PY - 2007

Y1 - 2007

N2 - Alopecia areata (AA) is a common dermatological disease, which affects nearly 2% of the general population. Association of AA with atopic disease has been repeatedly reported. Loss-of-function mutations in the filaggrin gene (FLG) may be considered as promising candidates in AA, as they have been observed to be a strong risk factor in atopic dermatitis. The FLG mutations R501X and 2282del4 were genotyped in a large sample of AA patients (n=449) and controls (n=473). Although no significant association was observed in the patient sample overall, FLG mutations were significantly associated with the presence of atopic dermatitis among AA patients. Furthermore, the presence of FLG mutations had a strong impact on the clinical course of AA in comorbid patients. For example, 19 of the 22 mutation carriers among AA patients with atopic dermatitis showed a severe form of the disease (P=0.003; odds ratio (OR)=5.47 (95% confidence interval (CI): 1.59-18.76)). In conclusion, our data suggest that when AA occurs in conjunction with FLG-associated atopic disorder, the clinical presentation of AA may be more severe.

AB - Alopecia areata (AA) is a common dermatological disease, which affects nearly 2% of the general population. Association of AA with atopic disease has been repeatedly reported. Loss-of-function mutations in the filaggrin gene (FLG) may be considered as promising candidates in AA, as they have been observed to be a strong risk factor in atopic dermatitis. The FLG mutations R501X and 2282del4 were genotyped in a large sample of AA patients (n=449) and controls (n=473). Although no significant association was observed in the patient sample overall, FLG mutations were significantly associated with the presence of atopic dermatitis among AA patients. Furthermore, the presence of FLG mutations had a strong impact on the clinical course of AA in comorbid patients. For example, 19 of the 22 mutation carriers among AA patients with atopic dermatitis showed a severe form of the disease (P=0.003; odds ratio (OR)=5.47 (95% confidence interval (CI): 1.59-18.76)). In conclusion, our data suggest that when AA occurs in conjunction with FLG-associated atopic disorder, the clinical presentation of AA may be more severe.

M3 - SCORING: Zeitschriftenaufsatz

VL - 127

SP - 2539

EP - 2543

JO - J INVEST DERMATOL

JF - J INVEST DERMATOL

SN - 0022-202X

IS - 11

M1 - 11

ER -